CYDY Financials 07/16/2014 03:22:19 CytoDyn, Inc.

CYDY Financials 07/16/2014 03:22:19
CytoDyn, Inc.
Period Ending May 31, 2014 May 31, 2013 May 31, 2012 May 31, 2011
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,981 620 530 481
Sales, General and Admin. 3,107 6,205 5,454 2,526
Non-Recurring Items 672 946 1,469 689
Other 352 223 2 3
Operating Income (8,113) (7,993) (7,456) (3,698)
Income From Continuing Operations
Add'l Income/Expense Items 192 374 (2) -
Earnings Before Interest and Tax (7,921) (7,619) (7,458) (3,698)
Interest Expense 4,510 1,949 17 21
Earnings Before Tax (12,431) (9,568) (7,474) (3,720)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,431) (9,568) (7,474) (3,720)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,431) (9,568) (7,474) (3,720)
Preferred Stock and Other Adjustments - (2) (89) (9)
Net Income Applicable to Common Shareholders (12,431) (9,570) (7,563) (3,728)